We are live on
!
Find out more
DekaBank Deutsche Girozentrale Portfolio holdings
AUM
$59.2B
1-Year Est. Return
26.02%
This Fund
S&P 500
This Quarter
Est. Return
+4.26%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$19.9B
AUM Growth
+$3.15B
(+19%)
Cap. Flow
+$2.87B
Cap. Flow
% of AUM
14.37%
Top 10 Holdings %
Top 10 Hldgs %
18.32%
Holding
1,356
New
166
Increased
640
Reduced
325
Closed
204
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$179M |
| 2 |
Amazon
AMZN
|
+$121M |
| 3 |
Alibaba
BABA
|
+$111M |
| 4 |
Merck
MRK
|
+$94.9M |
| 5 |
Comcast
CMCSA
|
+$78.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$88.1M |
| 2 |
Cisco
CSCO
|
+$82.5M |
| 3 |
NextEra Energy
NEE
|
+$74.9M |
| 4 |
Union Pacific
UNP
|
+$52M |
| 5 |
ESRX
Express Scripts Holding Company
ESRX
|
+$46.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Healthcare | 17.64% |
| 3 | Financials | 13.64% |
| 4 | Communication Services | 10.78% |
| 5 | Industrials | 8.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ONCE
776
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $1.04M | 0.01% |
10,164
-11,286
| -53% | -$1.22M |
|
777
Tootsie Roll Industries
TR
$2.98B
| $1.03M | 0.01% |
+34,493
| New | +$1.08M |
|
778
Sally Beauty Holdings
SBH
$1.58B
| $1.03M | 0.01% |
79,671
-8,040
| -9% | -$131K |
|
779
Vornado Realty Trust
VNO
$7.38B
| $1.03M | 0.01% |
15,552
+5,672
| +57% | +$381K |
|
780
Kinross Gold
KGC
$32.8B
| $1.03M | 0.01% |
264,989
-168,721
| -39% | -$569K |
|
|
DATA
781
DELISTED
Tableau Software, Inc.
DATA
| $1.02M | 0.01% |
5,963
+4,887
| +454% | +$642K |
|
782
Fate Therapeutics
FATE
$326M
| $1.02M | 0.01% |
+50,000
| New | +$901K |
|
783
Teledyne Technologies
TDY
$32B
| $1.02M | 0.01% |
3,800
+1,676
| +79% | +$418K |
|
784
Voya Financial
VOYA
$9.19B
| $1.01M | 0.01% |
18,061
-19,339
| -52% | -$1.04M |
|
|
RVNC
785
DELISTED
Revance Therapeutics, Inc.
RVNC
| $1.01M | 0.01% |
+80,000
| New | +$1.01M |
|
|
CVSA
786
Covista Inc
CVSA
$4.8B
| $1.01M | 0.01% |
22,185
+2,949
| +15% | +$135K |
|
787
Myriad Genetics
MYGN
$312M
| $1.01M | 0.01% |
37,600
+14,700
| +64% | +$415K |
|
788
EPR Properties
EPR
$4.77B
| $1M | 0.01% |
+13,519
| New | +$1.05M |
|
|
AQUA
789
DELISTED
Evoqua Water Technologies Corp. Common Stock
AQUA
| $1M | 0.01% |
72,673
-2,327
| -3% | -$30.2K |
|
790
MarketAxess Holdings
MKTX
$5.72B
| $997K | 0.01% |
+3,003
| New | +$868K |
|
|
WRK
791
DELISTED
WestRock Company
WRK
| $983K | ﹤0.01% |
26,357
+267
| +1% | +$9.81K |
|
|
AMED
792
DELISTED
Amedisys
AMED
| $981K | ﹤0.01% |
8,200
+4,600
| +128% | +$546K |
|
793
Iron Mountain
IRM
$36.1B
| $980K | ﹤0.01% |
30,639
+7,039
| +30% | +$231K |
|
794
Paycom
PAYC
$9.69B
| $958K | ﹤0.01% |
+4,084
| New | +$839K |
|
795
Toro Company
TTC
$9.49B
| $951K | ﹤0.01% |
14,200
-24,028
| -63% | -$1.69M |
|
796
Brinker International
EAT
$9.66B
| $944K | ﹤0.01% |
24,181
+18,785
| +348% | +$773K |
|
797
Helmerich & Payne
HP
$3.71B
| $942K | ﹤0.01% |
18,496
+7,927
| +75% | +$436K |
|
798
Teradyne
TER
$59.3B
| $938K | ﹤0.01% |
20,100
-76,087
| -79% | -$3.45M |
|
799
Flowserve
FLS
$10.2B
| $936K | ﹤0.01% |
17,576
+2,937
| +20% | +$144K |
|
800
HEICO Corp Class A
HEI.A
$37.2B
| $931K | ﹤0.01% |
8,797
+7,185
| +446% | +$662K |
|
Similar funds
QCM
NAMI
DekaBank Deutsche Girozentrale's Q2 2019 Portfolio in Review
As of Q2 2019, DekaBank Deutsche Girozentrale held 1,356 positions worth $19.9B, up 19% from $16.8B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
DekaBank Deutsche Girozentrale deployed $2.87B of net new capital in Q2 2019, opening 166 new positions and adding to 640 existing holdings. Its largest new stake was Alcon: 743,373 shares worth $45.4M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was TSMC, an estimated $88.1M trimmed.
- DekaBank Deutsche Girozentrale's largest Q2 2019 buy was Alcon: 743,373 shares worth $45.4M.
- DekaBank Deutsche Girozentrale added most to Procter & Gamble in Q2 2019, an estimated $179M increase.
- DekaBank Deutsche Girozentrale's biggest Q2 2019 reduction was TSMC, cutting an estimated $88.1M.
- DekaBank Deutsche Girozentrale fully exited Express Scripts Holding Company in Q2 2019, selling an estimated $46.5M.
- DekaBank Deutsche Girozentrale's ten largest holdings make up 18% of its $19.9B portfolio in Q2 2019.
- DekaBank Deutsche Girozentrale opened 166 new positions and closed 204 in Q2 2019.
- DekaBank Deutsche Girozentrale's portfolio value rose 19% quarter-over-quarter to $19.9B.
Based on DekaBank Deutsche Girozentrale's 13F filing for Q2 2019, filed 1 Aug 2019.